Skip to content

The effect of exercise intervention on chemotherapy-induced peripheral neuropathy in breast cancer patients: Feasibility and pilot studies

Construction and implementation of whole-course bone safety management intervention program for breast cancer patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072169
Enrollment
Unknown
Registered
2023-06-05
Start date
2022-12-26
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Group A:Exercise Intervention
Group B:Usual Care

Sponsors

Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis of breast cancer and knowledge of the disease. 2. 18 years of age = age = 65 years of age 3. Basic reading skills, internet access, and use of social networking software such as WeChat. 4. Informed consent and voluntary participation in this study. 5. Patients who have received at least 1 cycle of neurotoxic chemotherapeutic drugs 6. Patients with symptoms of chemotherapy-induced peripheral neuropathy, i.e. patients with symptoms of numbness, hypesthesia, abnormal sensation, pain, muscle spasm, muscle weakness, or even paralysis in the extremities after the use of neurotoxic chemotherapy drugs, and the diagnosis of peripheral neuropathy due to other pathological factors are excluded.

Exclusion criteria

Exclusion criteria: 1. Patients with other causes of peripheral neuropathy (e.g. diabetic peripheral neuropathy and neuropathy associated with nutritional deficiencies, etc.); 2. Patients with other serious medical conditions (e.g. severe hypertension, heart disease, etc.) that prevent them from cooperating with this study; 3. those with contraindications to exercise (blood clots in the lower limbs, artificial hips, etc.); 4. Patients with bone metastases or brain metastases; 5. Patients with other conditions that, in the opinion of the treating physician or nurse in charge, make them unsuitable for exercise.

Design outcomes

Primary

MeasureTime frame
Chemotherapy-Induced Peripheral Neuropathy Assessment Tool;

Secondary

MeasureTime frame
The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire;Physical Fitness Test;9-Hole Pegboard Test;

Countries

China

Contacts

Public ContactLiu Jun'e

Capital Medical University

liujune66@163.com+86 185 0013 6128

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026